# ANDA213868
> **ANDA213868** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA LLC · Approved 2025-11-06
## Drug
- **FDA Application Number:** ANDA213868
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** FRESENIUS KABI USA LLC
- **First approval:** 2025-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213868)
---
*AI Analytics · CC0 1.0*